臨床風險分組解決方案市場 - 按組件（軟體{私有和公共雲端}、服務）、應用程式（人口健康、慢性病管理、臨床決策支援）、最終用途（ASC、醫院和診所）、全球預測（2024 年-第2032章

Clinical Risk Grouping Solution Market - By Component (Software {Private & Public Cloud}, Service), Application (Population Health, Chronic Disease Management, Clinical Decision Support), End-use (ASC, Hospital & Clinic), Global Forecast (2024 - 2032)

出版日期: 2024年06月24日 | 出版商:

Global Market Insights Inc. | 英文 128 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於醫療保健系統中對有效風險管理和患者分層的需求不斷成長，預計 2024 年至 2032 年間，臨床風險分組解決方案市場規模的複合年成長率將達到 11.5%。由於醫療保健提供者專注於改善患者治療結果和最佳化資源分配，因此臨床風險分組解決方案有望為識別不良事件或併發症風險較高的患者提供有價值的工具。例如，2023 年 9 月，Reveleer 為風險承擔提供者推出了兩套新解決方案。

這些技術透過處理大量患者資料並識別傳統方法可能不明顯的模式，提高了風險評估的準確性和效率。這些解決方案與電子健康記錄 (EHR) 和其他醫療保健 IT 系統的整合也提高了它們的實用性和可近性，從而簡化了醫療保健提供者的風險管理流程。

整體產業成長分為組件、應用、最終用途和地區。

根據組成部分，服務領域的臨床風險分組解決方案市場預計在 2024 年至 2032 年期間將顯著成長。這是由於對實施和最佳化風險管理解決方案的全面支援和客製化。諮詢、培訓和持續技術支援等服務對於醫療保健組織有效地將臨床風險分組解決方案整合到其現有工作流程並最大限度地提高其效益至關重要。

預計到 2032 年，慢性病管理應用領域的臨床風險分組解決方案市場規模將大幅成長。臨床風險分組解決方案對於識別糖尿病、心血管疾病和呼吸系統疾病等慢性疾病的高風險患者至關重要，使醫療保健提供者能夠更準確地制定治療計劃和干涉措施。

預計到 2032 年，亞太地區臨床風險分組解決方案產業將大幅成長，這歸因於醫療保健數位化的快速發展以及在醫療保健成本不斷上漲的情況下對改善患者治療結果的日益重視。隨著多個亞太國家正在投資先進的醫療保健技術和電子病歷，對臨床風險分組解決方案的需求不斷成長，以加強患者分層並最佳化護理服務。

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

3M Corporation
4S Dawn Clinical Software
Apixio
Cotiviti Inc.
Evolent
HBI Solutions
Health Catalyst, Inc.
HealthEC LLC
Lightbeam Health Solutions
MedeAnalytics, Inc.
Nuance Communications, Inc.
Optum, Inc.
RELX (LexisNexis Risk Solution)
ZeOmega

簡介目錄

Product Code: 9982

Clinical risk grouping solution market size is anticipated to witness 11.5% CAGR between 2024 and 2032 driven by the increasing need for effective risk management and patient stratification in healthcare systems. As healthcare providers are focusing on improving patient outcomes and optimizing resource allocation, clinical risk grouping solutions are favored to offer valuable tools for identifying patients at higher risk of adverse events or complications. For instance, in September 2023, Reveleer unveiled two new suites of solutions for risk-bearing providers.

These technologies are enhancing the accuracy and efficiency of risk assessments by processing vast amounts of patient data and identifying patterns that may not be apparent through traditional methods. The integration of these solutions with electronic health records (EHRs) and other healthcare IT systems is also improving their utility and accessibility for streamlining the risk management process for healthcare providers.

The overall industry growth is divided into component, application, end-use and region.

Based on component, the clinical risk grouping solution market from the services segment is slated to witness significant growth during 2024-2032. This is due to the comprehensive support and customization for implementing and optimizing risk management solutions. Services, such as consulting, training, and ongoing technical support are essential for healthcare organizations to effectively integrate clinical risk grouping solutions into their existing workflows and maximize their benefits.

Clinical risk grouping solution market size from the chronic disease management application segment will foresee considerable growth up to 2032. This is owing to the need for effective patient stratification and monitoring in managing long-term health conditions. Clinical risk grouping solutions are essential for identifying high-risk patients with chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, allowing healthcare providers to tailor treatment plans and interventions more precisely.

Asia Pacific clinical risk grouping solution industry is anticipated to witness substantial growth through 2032 attributed to rapid healthcare digitization and increasing emphasis on improving patient outcomes amidst rising healthcare costs. As several APAC countries are investing in advanced healthcare technologies and EHRs, there is growing demand for clinical risk grouping solutions to enhance patient stratification and optimize care delivery.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360º synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing healthcare cost
  - 3.2.1.2 Rise in the adoption of electronic health records (EHR)
  - 3.2.1.3 Increasing investment in healthcare IT
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Data security and privacy concerns
  - 3.2.2.2 Regulatory and legal challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Software
- 5.2.1 Private cloud
- 5.2.2 Public cloud
- 5.2.3 Hybrid cloud
5.3 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Population health management
6.3 Chronic disease management
6.4 Clinical decision support
6.5 Fraud detection and prevention
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals & clinics
7.3 Ambulatory surgical centers
7.4 Long term care centers
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa